CO4900054A1 - Pirroles sustituidos - Google Patents

Pirroles sustituidos

Info

Publication number
CO4900054A1
CO4900054A1 CO97042636A CO97042636A CO4900054A1 CO 4900054 A1 CO4900054 A1 CO 4900054A1 CO 97042636 A CO97042636 A CO 97042636A CO 97042636 A CO97042636 A CO 97042636A CO 4900054 A1 CO4900054 A1 CO 4900054A1
Authority
CO
Colombia
Prior art keywords
alkyl
aryl
hydrogen
independently
formula
Prior art date
Application number
CO97042636A
Other languages
English (en)
Spanish (es)
Inventor
Hooda Dhingra Urvashi
Donna Mary Huryn
Dennis Dalton Keith
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of CO4900054A1 publication Critical patent/CO4900054A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrrole Compounds (AREA)
  • Indole Compounds (AREA)
CO97042636A 1996-07-29 1997-07-25 Pirroles sustituidos CO4900054A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2207896P 1996-07-29 1996-07-29
US4849697P 1997-06-03 1997-06-03

Publications (1)

Publication Number Publication Date
CO4900054A1 true CO4900054A1 (es) 2000-03-27

Family

ID=26695475

Family Applications (1)

Application Number Title Priority Date Filing Date
CO97042636A CO4900054A1 (es) 1996-07-29 1997-07-25 Pirroles sustituidos

Country Status (20)

Country Link
US (1) US6228877B1 (enExample)
EP (1) EP0915870B1 (enExample)
JP (1) JP2000516588A (enExample)
KR (1) KR20000029640A (enExample)
CN (1) CN1077571C (enExample)
AR (1) AR007969A1 (enExample)
AT (1) ATE224889T1 (enExample)
AU (1) AU740011B2 (enExample)
BR (1) BR9711607A (enExample)
CA (1) CA2262089A1 (enExample)
CO (1) CO4900054A1 (enExample)
DE (1) DE69715870T2 (enExample)
DK (1) DK0915870T3 (enExample)
ES (1) ES2183163T3 (enExample)
HR (1) HRP970415A2 (enExample)
MA (1) MA24354A1 (enExample)
PE (1) PE91598A1 (enExample)
PT (1) PT915870E (enExample)
TR (1) TR199900186T2 (enExample)
WO (1) WO1998004551A1 (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2208612C2 (ru) * 1998-03-17 2003-07-20 Ф.Хоффманн-Ля Рош Аг Замещенные бисиндолималеимиды, предназначенные для ингибирования пролиферации клеток
US6350786B1 (en) 1998-09-22 2002-02-26 Hoffmann-La Roche Inc. Stable complexes of poorly soluble compounds in ionic polymers
US6559164B1 (en) 1999-10-12 2003-05-06 Hoffmann-La Roche Inc. Substituted pyrroles suitable for continuous infusion
CN1155595C (zh) * 1999-10-12 2004-06-30 霍夫曼-拉罗奇有限公司 作为用于治疗癌症的抗增殖剂的取代的吡咯类化合物
US6313143B1 (en) * 1999-12-16 2001-11-06 Hoffmann-La Roche Inc. Substituted pyrroles
US6281356B1 (en) * 1999-12-22 2001-08-28 Hoffmann-La Roche Inc. Substituted pyrroles
US6326501B1 (en) * 2000-04-19 2001-12-04 Hoffmann-La Roche Inc. Methylation of indole compounds using dimethyl carbonate
US7129250B2 (en) 2000-05-19 2006-10-31 Aegera Therapeutics Inc. Neuroprotective and anti-proliferative compounds
CA2308994A1 (en) * 2000-05-19 2001-11-19 Aegera Therapeutics Inc. Neuroprotective compounds
TW201041580A (en) 2001-09-27 2010-12-01 Alcon Inc Inhibitors of glycogen synthase kinase-3 (GSK-3) for treating glaucoma
EP1441772A2 (en) * 2001-10-29 2004-08-04 Nektar Therapeutics Al, Corporation Polymer conjugates of protein kinase c inhibitors
CA2393720C (en) * 2002-07-12 2010-09-14 Eli Lilly And Company Crystalline 2,5-dione-3-(1-methyl-1h-indol-3-yl)-4-[1-(pyridin-2-ylmethyl)piperidin-4-yl]-1h-indol-3-yl]-1h-pyrrole mono-hydrochloride
WO2006086484A1 (en) 2005-02-09 2006-08-17 Arqule, Inc. Meleimide derivatives, pharmaceutical compositions and methods for treatment of cancer
MX2009006533A (es) * 2006-12-19 2009-06-26 Novartis Ag Derivados de indolil-maleimida como inhibidores de cinasa.
EP2170870B1 (en) * 2007-06-22 2014-03-05 ArQule, Inc. Pyrrolidinone, pyrrolidine-2, 5-dione, pyrrolidine and thiosuccinimide derivatives, compositions and methods for treatment of cancer
WO2009002808A2 (en) 2007-06-22 2008-12-31 Arqule, Inc. Quinazolinone compounds and methods of use thereof
JP5490688B2 (ja) 2007-06-22 2014-05-14 アークル インコーポレイテッド 癌の治療のためのインドリルピロリジン
GB201111427D0 (en) * 2011-07-05 2011-08-17 Amakem Nv Novel bisindolylmaleimides, pan-pkc inhibitors
EP3741375A1 (en) 2014-07-17 2020-11-25 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for treating neuromuscular junction-related diseases
WO2016207366A1 (en) 2015-06-26 2016-12-29 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and pharmaceutical compositions for the treatment of viral infections
CN109535158B (zh) * 2016-04-26 2021-04-23 浙江工业大学 一种双芳基马来酰亚胺类化合物及其药学上可接受的盐及其制备方法和应用
CN107973785B (zh) * 2017-11-27 2019-12-31 浙江工业大学上虞研究院有限公司 一种用于检测银离子的荧光探针及其制备方法和应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ227850A (en) * 1988-02-10 1991-11-26 Hoffmann La Roche Indole substituted pyrrole derivatives; preparatory process and medicaments for use against inflammatory immunological, bronchopulmonary or vascular disorders
PT93947B (pt) * 1989-05-05 1996-11-29 Goedecke Ag Processo para a preparacao de novos derivados de maleinimidas e de composicoes farmaceuticas que os contem
US5380746A (en) 1989-05-05 1995-01-10 Goedecke Aktiengesellschaft Bis-(1H-indol-3-YL)-maleinimide derivatives, processes for the preparation thereof and pharmaceutical compositions containing them
JPH0539289A (ja) 1991-02-15 1993-02-19 Masahiro Irie 無水マレイン酸誘導体およびその製造方法
EP0630241A1 (en) 1992-03-20 1994-12-28 The Wellcome Foundation Limited Indole derivatives with antiviral activity
DE4217964A1 (de) 1992-05-30 1993-12-02 Goedecke Ag Indolocarbazol-Imide und deren Verwendung

Also Published As

Publication number Publication date
CA2262089A1 (en) 1998-02-05
TR199900186T2 (xx) 1999-03-22
MA24354A1 (fr) 1998-07-01
EP0915870A1 (en) 1999-05-19
WO1998004551A1 (en) 1998-02-05
PE91598A1 (es) 1998-12-24
CN1077571C (zh) 2002-01-09
DK0915870T3 (da) 2003-02-03
HRP970415A2 (en) 1998-08-31
US6228877B1 (en) 2001-05-08
JP2000516588A (ja) 2000-12-12
KR20000029640A (ko) 2000-05-25
ATE224889T1 (de) 2002-10-15
BR9711607A (pt) 1999-08-24
ES2183163T3 (es) 2003-03-16
AU740011B2 (en) 2001-10-25
AR007969A1 (es) 1999-11-24
PT915870E (pt) 2003-01-31
DE69715870D1 (de) 2002-10-31
DE69715870T2 (de) 2003-06-18
AU4296397A (en) 1998-02-20
CN1226248A (zh) 1999-08-18
EP0915870B1 (en) 2002-09-25

Similar Documents

Publication Publication Date Title
CO4900054A1 (es) Pirroles sustituidos
CO4900055A1 (es) 3,4-di-indolil pirroles
ES544523A0 (es) Un procedimiento para la preparacion de derivados de benzodiazefinas.
ATE106401T1 (de) Benzodiazepin-analoge.
FR2733244B1 (fr) Systeme de stabilisants a base de derives de polyalkylpiperidine
NO20033765L (no) 4-Fenylpiperidinforbindelser
PE20021019A1 (es) Grupos azabiciclicos sustituidos
CO5031247A1 (es) Compuestos triciclicos sustituidos
AR241531A1 (es) Un procedimiento para la preparacion derivados de 2-indolinona, y sus sales farmaceuticamente aceptables.
PT1064281E (pt) Derivados de distamicina benzo-heterociclicos processo para os preparar e a sua utilizacao como agentes antitumorais
ES8504805A1 (es) Un procedimiento para la preparacion de imidazobenzodiacepinas
ES2150613T3 (es) Compuestos benzo-condensados de acepinona y piperidinona, utiles como inhibidores de ace y nep.
CO4960660A1 (es) Derivados de 5-aroil-pirrol-2-ilmetilareno, composiciones farmaceuticas que las contienen y metodos para la preparacion de estos compuestos
ES2075976T3 (es) Derivados de aminoacido y su empleo como agentes antiviricos.
ES2093286T3 (es) Bencimidazoles, medicamentos que contienen estos compuestos y procedimiento para su preparacion.
ES2051773T3 (es) Procedimiento para la obtencion de aralquil-4h,1,2,4-triazil derivados.
ECSP972205A (es) Pirroles sustituidos
ES2035919T3 (es) Composiciones fungicidas.
ECSP972206A (es) Pirroles sustituidos
PE25195A1 (es) Sintesis de l-aspartil-d-aminoalcanoil-(s)-o-alquilbencil amida utilizada como endulzante artificial
ES2140552T3 (es) Derivados indol como inhibidores de la 5-alfa-reductasa-1.
ES472429A1 (es) Un procedimiento para la preparacion de compuestos de 4Ÿ-de-soxi-4-amino-eritromicina a.
ES2129784T3 (es) Procedimiento de preparacion de un compuesto intermediario de sintesis y su uso.
NO963307D0 (no) Karbamoylmetylureaderivater
ECSP082418A (es) Heterociclos biciclicos disustituidos, su preparacion y su utilizacion como medicamentos